Trial Profile
The Comparison of Sugammadex and Conventional Cholinesterase Inhibitor on the Aspect of Postoperative Delirium in the Elderly Patients Undergoing Hip Surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Delirium
- Focus Therapeutic Use
- 01 Jan 2016 Status changed from recruiting to completed according to results published in the BioMed Research International.
- 09 Dec 2014 New trial record